Care during the continuation phase [Educational Series: Best Practice. Serialised Guide. Best practice for the care of patients with tuberculosis. Number 5 in the series]
Abstract:As the patient's treatment progresses, symptoms start to disappear and he or she becomes more familiar with the treatment. The standards in this section focus on the types of elements that need to be considered as the patient progresses from the intensive to the continuation phase of tuberculosis (TB) treatment, leading to less contact with the TB service and a resumption of ‘normal’ activities. Social and psychological as well as physical factors need to be assessed to plan effective care and treatment for the continuation phase. Treatment for TB takes a minimum of 6 months, during which changes to the regimen and personal changes associated with making a recovery can create barriers to continuation of treatment. Lifestyle and other changes that may occur during 6 months of anybody's life can complicate or be complicated by TB treatment. The patient may move to another location at any point during the course of treatment, in which case it may be necessary to transfer his or her care to another TB management unit. This process needs to be carefully managed to maintain contact with the patient and avoid any break in treatment; this is covered by the third standard in this chapter.
Document Type: Invited Paper
Affiliations: 1: International Union Against Tuberculosis and Lung Disease, Paris, France; International Council of Nurses, Geneva, Switzerland 2: International Union Against Tuberculosis and Lung Disease, Paris, France 3: Ministry of Public Health, Bangkok, Thailand 4: Ministry of Health, Kampala, Uganda 5: KNCV, The Hague, The Netherlands 6: State Agency of Tuberculosis and Lung Diseases, Riga, Latvia 7: Sao Paulo University, Sao Paulo, Brazil
Publication date: 2008-07-01
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.
Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites